Treating the Host Response to Ebola Virus Disease with Generic Statins and Angiotensin Receptor Blockers
ABSTRACT Treatments targeting the Ebola virus may eventually be shown to work, but they will not have an impact on overall Ebola mortality in West Africa. Endothelial dysfunction is responsible for the fluid and electrolyte imbalances seen in Ebola patients. Because inexpensive generic statins and a...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2015-07-01
|
Series: | mBio |
Online Access: | https://journals.asm.org/doi/10.1128/mBio.00716-15 |